Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study

Sangha Kim1, Seong Hye Choi2, Young Min Lee3

  • 1Department of Psychiatry,Samsung Medical Center,Sungkyunkwan University School of Medicine,Seoul,South Korea.

Abstract

Insights

White matter hyperintensities (WMH) in the brain differentially predict dementia subtypes. Periventricular WMH are linked to Alzheimer's disease and all-cause dementia, while both periventricular and deep WMH predict vascular dementia.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • Cerebral white matter hyperintensities (WMH) are common MRI findings in older adults, linked to cognitive decline.
  • The specific regional impact of WMH on cognitive function and dementia progression remains unclear.

Purpose of the Study:

  • To investigate the differential role of regional white matter hyperintensities (WMH) in predicting the progression from mild cognitive impairment (MCI) to various dementia subtypes.

Main Methods:

  • 622 participants with MCI from the CREDOS study were analyzed.
  • Initial MRI scans were assessed for WMH using a visual rating scale.
  • Cox proportional hazards models evaluated regional WMH effects on dementia incidence.

Main Results:

  • 139 (22.3%) participants converted to dementia over a median of 14.3 months.
  • Severe periventricular WMH (PWMH) predicted all-cause dementia and Alzheimer's disease.
  • Both PWMH and deep WMH (DWMH) predicted subcortical vascular dementia.

Conclusions:

  • WMH exhibit regional and severity-dependent predictive power for dementia.
  • PWMH may independently contribute to dementia pathogenesis, particularly Alzheimer's disease.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
719
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K